Larry Trittschuh - HealthEquity Executive Vice President Chief Security Officer
| HQY Stock | USD 112.07 0.10 0.09% |
President
Mr. Larry Trittschuh is Executive Vice President, Chief Security Officer of the Company. Mr. Trittschuh will join HealthEquity from his current position as CSO for Barclays Americas. Mr. Trittschuh was Senior Vice President, Information Security for Synchrony Financial prior to joining Barclays, and was Executive Director, Threat Management Deputy Chief Information Security Officer for General Electric prior to that. Mr. Trittschuh has more than 25 years of experience including service in the USAF since 2018.
| Age | 52 |
| Tenure | 7 years |
| Address | 15 West Scenic Pointe Drive, Draper, UT, United States, 84020 |
| Phone | 801 727 1000 |
| Web | https://www.healthequity.com |
Larry Trittschuh Latest Insider Activity
Tracking and analyzing the buying and selling activities of Larry Trittschuh against HealthEquity stock is an integral part of due diligence when investing in HealthEquity. Larry Trittschuh insider activity provides valuable insight into whether HealthEquity is net buyers or sellers over its current business cycle. Note, HealthEquity insiders must abide by specific rules, including filing SEC forms every time they buy or sell HealthEquity'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Larry Trittschuh over a year ago Exercise or conversion by Larry Trittschuh of 6419 shares of HealthEquity subject to Rule 16b-3 | ||
Larry Trittschuh over a year ago Payment of 3438 shares by Larry Trittschuh of HealthEquity subject to Rule 16b-3 | ||
Larry Trittschuh over a year ago Acquisition by Larry Trittschuh of 15006 shares of HealthEquity subject to Rule 16b-3 | ||
Larry Trittschuh over a year ago Payment of 100 shares by Larry Trittschuh of HealthEquity subject to Rule 16b-3 |
HealthEquity Management Efficiency
The company has Return on Asset of 0.034 % which means that on every $100 spent on assets, it made $0.034 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0515 %, implying that it generated $0.0515 on every 100 dollars invested. HealthEquity's management efficiency ratios could be used to measure how well HealthEquity manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to 0.13 in 2025, whereas Return On Capital Employed is likely to drop 0.05 in 2025. At this time, HealthEquity's Total Assets are fairly stable compared to the past year. Other Current Assets is likely to rise to about 58.6 M in 2025, whereas Other Assets are likely to drop 1.09 in 2025.Similar Executives
| Found 5 records | PRESIDENT Age | ||
| Jason Randall | Appfolio | 51 | |
| Keith Pfeil | Globus Medical | 46 | |
| Brett Murphy | Globus Medical | 59 | |
| Daniel Scavilla | Globus Medical | 60 | |
| David Demski | Globus Medical | 62 | |
Management Performance
| Return On Equity | 0.0515 | ||||
| Return On Asset | 0.034 |
HealthEquity Leadership Team
Elected by the shareholders, the HealthEquity's board of directors comprises two types of representatives: HealthEquity inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HealthEquity. The board's role is to monitor HealthEquity's management team and ensure that shareholders' interests are well served. HealthEquity's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HealthEquity's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Cheryl King, Executive Officer | ||
| Elimelech Rosner, Executive CTO | ||
| Tia Padia, Executive Officer | ||
| Richard Putnam, IR Contact Officer | ||
| Larry Trittschuh, Executive Vice President Chief Security Officer | ||
| James Lucania, CFO VP | ||
| Delano JD, General VP | ||
| Jon Kessler, CEO and President and Director | ||
| Angelique Hill, Executive Vice President - Operations | ||
| Darcy Mott, CFO, Executive VP and Treasurer | ||
| Stephen Neeleman, Vice Chairman of the Board, Founder | ||
| Delano Ladd, Executive Vice President General Counsel and Corporate Secretary | ||
| Brad Bennion, Senior Development | ||
| Tyson Murdock, Ex CFO | ||
| Steve Lindsay, Executive Management | ||
| Kamesh Tumsi, Senior Product |
HealthEquity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is HealthEquity a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0515 | ||||
| Return On Asset | 0.034 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 10.52 B | ||||
| Shares Outstanding | 86.66 M | ||||
| Shares Owned By Insiders | 2.06 % | ||||
| Shares Owned By Institutions | 97.94 % | ||||
| Number Of Shares Shorted | 4.52 M | ||||
| Price To Earning | 525.29 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for HealthEquity Stock Analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.